XBIT
XBiotech Inc

2,679
Mkt Cap
$65.85M
Volume
79,332.00
52W High
$7.64
52W Low
$2.09
PE Ratio
-2.26
XBIT Fundamentals
Price
$2.22
Prev Close
$2.16
Open
$2.23
50D MA
$2.57
Beta
1.15
Avg. Volume
58,989.57
EPS (Annual)
-$1.26
P/B
0.39
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
XBiotech (NASDAQ:XBIT) Releases Earnings Results
XBiotech (NASDAQ:XBIT - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.20) earnings per share for the quarter...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc...
PR Newswire·10mo ago
News Placeholder
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm...
PR Newswire·10mo ago
News Placeholder
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. (XBiotech or the Company) (NASDAQ: XBIT) for...
Business Wire·10mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech...
PR Newswire·11mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech...
PR Newswire·11mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech...
PR Newswire·11mo ago
News Placeholder
What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?
XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin...
Benzinga·1y ago
News Placeholder
XBiotech (XBIT, $7.83) RSI Indicator left the overbought zone on April 01, 2024
This is a signal that XBIT's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
XBiotech (XBIT, $8.03) price may drop as it broke higher Bollinger Band on Mar 26, 2024
This price move could be a signal that XBIT may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago

Latest XBIT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.